158 related articles for article (PubMed ID: 11999362)
1. Acute basophilic leukemia lacking basophil-specific antigens: the importance of cytokine receptor expression in differential diagnosis.
Yokohama A; Tsukamoto N; Hatsumi N; Suto M; Akiba T; Uchiumi H; Maehara T; Matsushima T; Karasawa M; Murakami H; Shinonome S; Saito H; Nojima Y
Int J Hematol; 2002 Apr; 75(3):309-13. PubMed ID: 11999362
[TBL] [Abstract][Full Text] [Related]
2. Acute basophilic leukemia presenting with abnormal liver function tests and the absence of blast cells in the peripheral blood.
Scolyer RA; Brun M; D'Rozario J; Webb M
Pathology; 2000 Feb; 32(1):52-5. PubMed ID: 10740808
[TBL] [Abstract][Full Text] [Related]
3. [A case of de novo acute basophilic leukaemia: diagnostic criteria and review of the literature].
Staal-Viliare A; Latger-Cannard V; Rault JP; Didion J; Grégoire MJ; Bologna S; Witz B; Jonveaux P; Lecompte T; Rio Y
Ann Biol Clin (Paris); 2006; 64(4):361-5. PubMed ID: 16829481
[TBL] [Abstract][Full Text] [Related]
4. Acute basophilic leukemia: case report.
Gupta R; Jain P; Anand M
Am J Hematol; 2004 Jun; 76(2):134-8. PubMed ID: 15164378
[TBL] [Abstract][Full Text] [Related]
5. Acute basophilic leukemia.
Giagounidis AA; Hildebrandt B; Heinsch M; Germing U; Aivado M; Aul C
Eur J Haematol; 2001 Aug; 67(2):72-6. PubMed ID: 11722593
[TBL] [Abstract][Full Text] [Related]
6. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
7. [Acute basophilic leukemia: a case report].
Iehara K; Tashiro E; Ashihara E; Okawa K; Oku N; Goto H; Inaba T; Ito K; Fujita N; Shimazaki C
Rinsho Ketsueki; 1993 Jul; 34(7):847-52. PubMed ID: 7689662
[TBL] [Abstract][Full Text] [Related]
8. Acute basophilic leukemia.
Eveillard M; Desjonqueres A
Blood; 2014 May; 123(20):3071. PubMed ID: 24949509
[No Abstract] [Full Text] [Related]
9. [Basophilic differentiation of leukemic cells in a patient with acute leukemia carrying minor bcr/abl chimeric mRNA].
Igarashi Y; Hayashi T; Sato S; Kato T
Rinsho Ketsueki; 2001 Jul; 42(7):559-64. PubMed ID: 11524847
[TBL] [Abstract][Full Text] [Related]
10. Acute basophilic leukemia with t(8;21).
Seth T; Vora A; Bhutani M; Ganessan K; Jain P; Kochupillai V
Leuk Lymphoma; 2004 Mar; 45(3):605-8. PubMed ID: 15160925
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of acute basophilic leukemia.
Duchayne E; Demur C; Rubie H; Robert A; Dastugue N
Leuk Lymphoma; 1999 Jan; 32(3-4):269-78. PubMed ID: 10037024
[TBL] [Abstract][Full Text] [Related]
12. Monosomy 7 as the sole abnormality of an acute basophilic leukemia.
Shin SY; Koo SH; Kwon KC; Park JW; Ko CS; Jo DY
Cancer Genet Cytogenet; 2007 Jan; 172(2):168-71. PubMed ID: 17213028
[TBL] [Abstract][Full Text] [Related]
13. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
[TBL] [Abstract][Full Text] [Related]
14. Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Candoni A; Martinelli G; Toffoletti E; Chiarvesio A; Tiribelli M; Malagola M; Piccaluga PP; Michelutti A; Simeone E; Damiani D; Russo D; Fanin R
Leuk Res; 2008 Dec; 32(12):1800-8. PubMed ID: 18621416
[TBL] [Abstract][Full Text] [Related]
15. [Acute basophilic leukemia with an intense erythroblastic reaction].
Batlle M; Ribera JM; García-Vidal O; Roncalés J; Millá F; Feliu E
Sangre (Barc); 1993 Oct; 38(5):385-7. PubMed ID: 8140501
[TBL] [Abstract][Full Text] [Related]
16. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
[TBL] [Abstract][Full Text] [Related]
17. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
18. Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia.
Boveri E; Castagnola C; Castello A; Magrini U
Am J Hematol; 2008 May; 83(5):428-9. PubMed ID: 17617786
[No Abstract] [Full Text] [Related]
19. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
20. Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
Carella AM; Frassoni F; Podestá M; Pungolino E; Pollicardo N; Ferrero R; Soracco M
J Hematother; 1994; 3(3):199-202. PubMed ID: 7530135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
